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ABSTRACT 
Objective: The aim of this study was to evaluate the effect of thymol and thymol nano polymer on the blood biochemical parameters and anti-
diabetic activity in Streptozotocin (STZ)-induced diabetic rats.  
Methods: The synthesized nano polymer (NP) was characterized by using different spectroscopy methods, such as IR, HNMR and CNMR. Loading 
and releasing of thymol were investigated by HPLC. Eleven groups of the Streptozotocin-induced diabetic and normal rats (overall 110 males) were 
tested through various biochemical factors such as: serum glucose, insulin, liver function-related enzymes including ALT, AST, ALP and bilirubin by 
ELISA kit methods.  
Results: It has shown that thymol nano polymer is desirable for transferring drug. The amount of thymol loaded on NP estimated at 43±2.5 %. 
Then, 65% of the loaded drug was released. LD50 for thymol and thymol nano polymer were 435 and 583 mg/kg, respectively. thymol nano polymer 
at doses of 30, 60 and 90 mg/kg, in a dose-dependent manner, reduced blood glucose, increased insulin levels, and controlled liver enzymes ALT, 
AST, ALP and bilirubin in the STZ-induced diabetic rats. 
Conclusion: The use of thymol nano polymer appears to be a new aspect concerning to protect diabetes-induced damage in the animal model.  
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One of the most common metabolic diseases is diabetes mellitus 
(DM), which is defined by hyperglycemia due to the weakness of 
body cells to use glucose properly [1]. It is likely that by the year 
2030 about 500 million people will get diabetes [2]. Hyperglycemia 
is the common symptom of these diseases that alterative of glucose 
and changes in liver enzyme levels [3]. These changes include 
abnormal liver enzyme levels, necrosis, inflammation, cirrhosis, 
hepatocellular carcinoma, hepatitis, nonalcoholic fatty liver disease 
and acute liver failure [4]. Fluctuating levels of alkaline phosphatase 
(ALP), aspartate aminotransferase (AST) and alanine 
aminotransferase (ALT) are mostly the result of the leakage of these 
enzymes from the cytosol of hepatocytes in the bloodstream [5]. 
Treatment for this pathology is multifaceted, which includes 
physical activity, dietary changes, and decrease in absorption of 
glucose in the gastrointestinal system and drug therapy [6]. Despite 
the use of common drugs, the development of new methods with 
fewer side effects to prevent DM is growing in the field of 
ethnobotanical treatments [7]. So, the hypoglycemic activity of a 
number of medicinal plant extracts has been evaluated and 
confirmed in animal models [8]. Previously, extracts of herbs such as 
Syzygium cumini and Psidium guajava have been identified as 
effective compounds for diabetes mellitus [9]. It has also been shown 
that the root extract of ashwagandha has improved diabetic 
disorders by reducing oxidative stress [10]. 
An important part of the essential oil of plants such as Thymus 
vulgaris is thymol, which is widely used as a flavoring and 
preservation capacity in the food industry. It has also been used in 
folk medicine since the ancient Greeks, Egyptians and Romans [11]. 
Studies have shown that thymol has antioxidant and anti-
inflammatory properties [12, 13]. The antioxidant effects maybe 
return to its phenolic structure, as phenolic compounds often exhibit 
redox properties, which may adsorb and neutralize free radicals [14, 
15]. Also, the ant diabetic effects of thymol on high fat diet-induced 
diabetic mice have been reported previously [16]. On the other hand, 
it has been shown that thymol is bonded to a variety of 
nanoparticles for various diseases [17, 18]. 
Nanoscale drug carriers are generally synthesized from natural and 
polymeric materials for slow and targeted release in sizes of 10 to 
1,000 nm. Therefore, because the structure of drug carriers has 
important benefits such as biocompatibility and biodegradability, it 
is widely used to develop pharmaceutical industries. Nanoparticles, 
either encapsulated or absorbed, carry the drug more effectively to 
be used in the target tissue [19].  
Thus, this is the first study that was initiated with the aim of 
evaluating the effect of thymol and thymol nano polymer on the 
blood biochemical parameters and anti-diabetic activity in 
Streptozotocin-induced diabetic rats. The efficacy was compared 
with glibenclamide, a standard hypoglycemic drug. 
MATERIALS AND METHODS 
Preparation and characterization of nano polymer  
By using Citric acid (CA) (Carlo Erba) as AB3 monomer and glycerol 
(G) (Carlo Erba) as A3 monomer at different CA/G molar feed ratios, 
nano branching polymers were synthesized through the melting 
polycondensation. Glycerol (0.5 ml, 6.6 mmol) and CA 
monohydrate7 g (33 mmol), 11.09 g (52.8 mmol), and 16.64 g (79.2 
mmol), corresponding to the CA/G molar feed ratios of 5, 8, and 12 
respectively, were mixed in a polymerization ampule equipped with 
gas inlet, vacuum inlet, and magnetic stirrer at 90 °C, and heated to 
110 °C for 20 min under constant stirring. The temperature of the 
polymerization ampoule was increased and adjusted to 120 °C for 30 
min, 130 °C for 40 min, 140 °C for 40 min, 145 °C for 50 min and 150 
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for 60 min, respectively under vacuum to remove the water formed 
during the reaction. The mixture was cooled at room temperature. 
Viscose compound was dissolved in Tetrahydrofuran (THF) (Merck) 
and filtered to obtain a clear solution. The resulting solution was 
then concentrated under reduced pressure and was precipitated 
several times in cyclohexane (Merck). Precipitated compound (1 g) 
was dissolved in THF (10 ml) and then placed in a dialysis bag (Mn 
cutoff 2000, sigma-Aldrich) immersed in THF (100 ml) for 4 h and 
THF in the outside medium of dialysis bag was replaced with the 
fresh solvent. Finally, to obtain pure product as colorless and viscose 
compound, THF was evaporated under the reduced pressure. In the 
Second step, nano polymer modified by oleic acid (NP) was 
synthesized. Frist 3 g initial nano polymer was poured in a 
polymerization capsule and then 192 μl oleic acid was added. The 
resulting mixture was then heated at 90, 100, 120, 140 and 160 °C 
respectively, and stirrer at 1,000 rpm magnetic stirrer for 5 h under 
the vacuum condition. To remove residue oleic acid, the mixture was 
washed several times with n-hexane. Then, it was washed in 20 ml 
ethanol. The produced polymer and ethanol solvent were put into a 
dialysis bag up at room temperature for 4 h [20].  
Fourier transforms infrared (FTIR) spectroscopy 
The IR spectra of the NP were performed with a Nicolet 320 
spectrophotometer FT-IR spectrometer which was prepared by 
mixing the fine powder with KBr and pressing. The spectra were 
obtained at a resolution of 4 cm-1in the range 4,000–500 cm-1 21[ ]. 
Nuclear magnetic resonance (NMR) 
All NMR experiments were conducted on a Bruker DRX 400 (400 
MHz, USA) apparatus in D2O as solvents. Identical spectra were 
obtained by dissolving samples in D2O and the spectra were 
recorded at 500 MHz (in1H and 13
22
C NMR spectra for all temperatures 
and concentrations). The resulting data were processed and 
analyzed using ACDLABS/1D NMR software [ ]. 
Encapsulation of thymol and extract by NP 
One-tenth gram (1.67×10-2
23
 mmol) of NP was dissolved in 5 ml 
distilled water and stirred for one h. Then thymol (Sigma Aldrich) 
dissolved in Dimethyl sulfoxide (DMSO)(Merck) as stock solutions 
(0.1 mmol) was added dropwise to NP mixture and various 
concentrations of thymol were obtained (25, 50, 100, 150 µM). 
These solutions were sonicated at room temperature for obtaining 
the final product [ ].  
Loading and releasing capacity by HPLC method 
HPLC method was used to determine the loading capacity, according 
to previous studies [24]. To estimate the amount of pure thymol 
loaded on NP, a reversed-phase HPLC with a Knauer liquid 
chromatography (Smart line; Knauer, Berlin, Germany) equipped 
with an ultraviolet detector (Well chrome, K-2600; Knauer) and a 
reverse-phase C18 column (Nucleosil H. P.; 25 cm _ 0.46 cm internal 
diameter, pore size mm; Knauer) using isocratic elution with UV 
absorbance detection was used. The mobile phase was made up of 
40% methanol and 60% aqueous solution of formic acid (0.1%). The 
test equipment was calibrated at a wavelength of 284 nm with a 
column temperature of 25 ° C, with a volume of injection of 1 μl, and 
a mobile phase flow rate of 1 ml/min. After 1 h sonication for 
encapsulation, a water solution of NP-pure thymol was prepared. To 
remove the non-encapsulated pure thymol residue, the solution was 
centrifuged at 10,000 rpm and, after precipitation, the supernatant 
was filtered [25]. An aliquot of the solution after filtration was 
injected into the HPLC to determine the concentration of 
encapsulation. In vitro release of pure thymol from NP was carried 
out by dissolving 5 mg of pure thymol loaded NP in 3 ml of PBS (0.1 
M, pH 7.4). The NP solutions containing the pure thymol (1 ml) were 
manipulated according to the previous section [26].  
Experimental animals 
In the present study, one hundred ten Wistar rats (Pasteur Institute 
of Iran), weighing 240±30 g were used. The animals were easily 
accessible to standard water and pellet diet and were kept in 
standard plastic cages in 12 h of darkness and 12 h of light at an 
ambient temperature of 25±2. To acclimatize them to the laboratory 
environment, it was given ten days before the time of the study. The 
ethical approval for this study was obtained from the Animal Care 
and Ethics Committee (ACEC) of the Ilam University of medical 
science (IR. MEDILAM. REC.1396.84). According to ACEC 
recommendations, we tried our best to minimize research animal 
pain and suffering. To minimize effects of transportation-induced 
physiological changes on subsequent biomedical research, it is 
advisable to consider two factors According to the first factor, in the 
present study, it was noted that the animal transfer according to the 
physiological conditions in accordance with the international 
protocols with the least stress of the animal is carried out and 
according to the second factor, in general, mediators of stress 
response to reach the desired conditions (for example, for 24 h) Was 
considered. 
Acute toxicity test (LD50) 
The toxicity test of the thymol and thymol nano polymer were 
carried out using the Acute Toxic Method [38]. Each dose of thymol 
and thymol nano polymer were administered to three male rats 
(240–250 g; total). The initial dose of 10 mg/kg was gradually 
increased up to 1500 mg/kg, according to the mortality rate during 
the 24 h exposure period. The animals were kept under observation 
for 14 d [27]. 
Induction of diabetes 
Diabetes was induced in overnight fasted Wistar rats by single dose 
intraperitoneal injection of freshly prepared Streptozotocin (STZ) 
(Sigma-Aldrich) at 60 mg/kg body weight. Positive control for 
diabetic rats, glibenclamide (2.5 mg/kg, Merck) has been used. The 
non-diabetic rats (negative control) also received normal saline. 
After 72 h STZ administration, tail blood samples of the overnight 
fasted rats were collected to measure blood glucose levels [28].  
Experimental design 
To evaluate the anti-hyperglycemic effect of thymol in normal and 
STZ-induced diabetic rats, the animals were divided into 11 equal 
groups (n=10), as follows:  
Group 1: Untreated diabetic rats;  
Group 2: Untreated normal rats;  
Group 3: Normal rats treated with thymol (60 mg/kg). 
Group 4: Normal rats treated with thymol nano polymer (60 mg/kg) 
Group 5: Diabetic rats treated with thymol (30 mg/kg) 
Group 6: Diabetic rats treated with thymol (60 mg/kg) 
Group 7: Diabetic rats treated with thymol (90 mg/kg) 
Group 8: Diabetic rats treated with thymol nano polymer (30 
mg/kg) 
Group 9: Diabetic rats treated with thymol nano polymer (60 
mg/kg) 
Group 10: Diabetic rats treated with thymol nano polymer (90 
mg/kg) 
Group 11: Diabetic rats treated with glibenclamide (2.5 mg/kg) 
Ten days after induction of diabetes, the diabetic animals received 
the thymol, thymol nano polymer and glibenclamide, respectively. 
Non-diabetic animals received (60 mg/kg) thymol and thymol nano 
polymer by gastric gavage needle (NG tube). The untreated normal 
and diabetic rats were given normal saline [28]. 
Collection of blood and determination of biochemical 
parameters 
Blood samples were collected from tail vein rat in 2 w after the 
administration of thymol and thymol nano polymer and blood 
glucose levels were determined. At the completion of the treatments, 
the animals were fasted overnight and then blood samples were 
drawn from their retro-orbital plexus. Immediately after blood 
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samples collection, serum was isolated by centrifugation at 3,000 
rpm for 10 min and then analyzed for various biochemical 
parameters. The serum samples were stored at −80 °C in a freezer 
until they were analyzed. For biochemical analysis were used 
standard commercial kits according to the manufacturer's 
instructions. Fasting serum glucose level was determined on day 14 
by glucose oxidase-peroxidase method using the kit. Alanine and 
aspartate aminotransferase (ALT and AST) and alkaline phosphatase 
(ALP) were measured using kits (Nanjing Jiangcheng Bioengineering 
Institute, Nanjing, China). Serum bilirubin was determined using a 
commercial kit (RANDOX Laboratories Ltd., UK) [28]. 
Statistical analysis 
The results were expressed as mean±SD. Data analysis was 
performed by the SPSS version 21 using one-way analysis of 
variance (ANOVA) tests. To assess the individual variations between 
the control and treatment groups, P<0.05 was considered the 
significance level. Terms half-maximal lethal dose (LD50) refers to 
the concentration of a chemical, drug or toxic substance that 
produces a response halfway between the baseline and maximum 
after a specified exposure time. 
RESULTS 
Evaluation of hyperbranched polyester  
By using spectroscopic methods such as IR spectra, 1H, and 13C NMR 
spectra, the structure of the synthesized nano polymer modified by 
oleic acid (NP) were evaluated. The IR spectrum of the NP 
compound is shown in fig. 1. The peak of the carbonyl group appears 
at 1738 ppm. This displacement in this spectrum is due to the 
formation of a new carbon derived from the carbonyl group, which is 
derived from the combination of hydroxyl groups of the NP 
compound with the oleic acid. As shown in the fig., after the addition 
of the oleic acid group (due to the presence of a long chain of 
carbon) to the NP compound, the peak strength of the hydroxyl 
group in the NP composition decreased to the NP compound, with a 
peak of 3485 ppm. 
 
 
Fig. 1: FT-IR spectrum of nano polymer modified by oleic acid (NP) 
 
 
Fig. 2: 1H NMR spectrum of nano polymer modified by oleic acid (NP) in D2O 
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The HNMR spectrum of the NP compound is shown in fig. 2. For a 
more straightforward interpretation, these combinations of 
hydrogens with identical positions are named with the same letters. 
Hydrogen A is the hydrocarbon content of the monomeric citric acid 
present in the compound, a single peak at the highest intensity at 
4.37 ppm. Hydrogen B is actually single hydrogen-related monomer 
glycerol, which appears at 3.87 ppm. Hydrogen C is methylated 
glycerol, which has two separate couriers due to the presence of 
neighbor hydrogen. Hydrogen D is related to the methane adjacent 
to the carbonyl group in the oleic acid monomer, split into a triplet 
peak at 2.45 ppm due to the presence of two hydrogen neighbors. 
Hydrogen E is a methyl group adjacent to hydrogen D, which has 
been split into a five-pixel peak due to the presence of four hydrogen 
neighbors. Hydrogen, named after the letter "F", appears in a single-
pixel at 2 ppm because of the same space-spatial position. Because of 
the dual-bonded proximity to hydrogen, I hydrogen has a different 
position with neighboring hydrogen and appears as a peak in the 
range of 2.2 to 2.3 ppm. The G-hydrides appear to be in the form of a 
double peak at 5.26 ppm due to the presence of the double bond, and 
eventually, the J-hydrides belong to the end-methyl group of the 
oleic acid chain, which, with minimal displacement, is a 
multiplicative peak at 1.15 ppm appear. 
The CNMR spectrum of the NP compound is presented in fig. 3. 
Regarding the fact that there are 12 types of carbon in the synthetic 
composition, in the CNMR spectrum, this combination has a 12-peak 
index of the carbon compounds of this composition, which, 
according to the form, is named all the carbons with the letters A to 
M, each of which Are on the spectrum. Equivalent carbon is indicated 
by a letter as described below. Carbon A is the middle carbonic acid 
group of citric acid, which appears at the end of the spectrum with a 
displacement of 177 ppm. Carbon B is the fourth type of citric acid 
that appears at 42 ppm. Methionine citric acid carbonated with the 
letter C appears at 28 ppm. The two carboniferous carbon 
represented by the letter D appears at 172 ppm. The middle carbon 
of glycerol is marked with the letter E, which is given at 73 ppm. 
Methyl glycerol carbonates have been identified with the letter F, 
which appear as a peak at the highest intensity of 68 ppm. Carbon 
is the carbonyl oleic acid group with the letter G, which has the 
largest displacement and peak at 183 ppm. Carbonyl adjacent 
carbonyl oleic acid group has a specific displacement due to its 
direct connection with the carbonyl group, with a different 
displacement than its other neighboring carbon, with the letter H 
marked with a peak of 38 ppm. Carbon labeled with the letter "I" 
has a roughly identical position and appears as a peak of more 
intensity than the other oleic acid carbon at 26 ppm. The adjacent 
dual-carbon carbons are positioned differently from other 
neighboring carbon and are marked with the letter J and have a 
peak at 21PPM. The carbons that are connected by a double bond 
are named with the letter K and appear as a peak at 130 ppm. At 
the end of the carbon, the methyl group has appeared with a 
minimum displacement of 9 ppm. 
 
 
Fig. 3: 13C NMR spectrum of nano polymer modified by oleic acid (NP) in D2O 
 
 
Fig. 4: In vitro release of thymol loaded NP (0.1 g, 1.67×10-2 mmol) in distilled water (HPLC grade) at 37 °C. Data represented as 
mean±SEM, (n=3) 
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Evaluation of the loading and releasing  
By HPLC, loading capacity and release of thymol were evaluated 
from the NP. Thymol standard curve was used to calculate thymol 
loaded into the NP. After three repetitions and injection into HPLC, 
the loading rate of thymol was estimated at 43±2.5 %.  
Thymol was released in two fast and slow phases of the NP. In the 
first twelve hours, approximately 65% of thymol released from a fast 
and steep gradient of thymol nano Polymer, and the remaining 80-
85 % to 48 h was released at a lower rate and less slope. NP showed 
slow biphasic release kinetics with a faster release phase during the 
initial period as shown in fig. 4. 
Toxicity test (LD50) 
The result of the acute toxicity test showed that the LD50 for thymol and 
thymol nano polymer were 435 and 583 mg/kg, respectively. So doses of 
30, 60 and 90 mg/kg were selected to continue the experiment. 
Effect of thymol and thymol nano polymer on body weights  
Bodyweight of different tested groups was recorded in table 1. There 
was no significant difference in body weight between groups before 
induction of diabetes. By the end of the second week after induction of 
diabetes, diabetes symptoms appeared such as weight loss when 
compared with the non-diabetic rats. A significant (P<0:05) decrease 
(14.6%) in the body weights of diabetic rats was observed after 
induction of STZ in the animals. Weight loss, in the group treated with 
thymol nano-polymer 90 mg/kg, similar to diabetic group. 
Effect of thymol and thymol nano polymer on hyperglycemia of 
diabetic and normal rats 
The results show that after induction diabetes, in untreated diabetic rats 
(Group 1), serum glucose levels increased compared to those of non-
diabetic rat (Group 2) in weeks 2. Treatment with thymol and thymol 
nano polymer at 30, 60 and 90 mg/kg for 2 w reduced the glucose 
concentration in diabetic rats by dose-dependent manner, respectively. 
In non-diabetic groups (group 3 and 4), 60 mg of thymol and thymol 
nano-polymer were used, which was not significantly different from 
glucose level in group 2. (table 2, P<0.05). 
Effect of thymol and thymol nano polymer on an insulin level of 
diabetic and normal rats 
The results show that in the groups treated with thymol and thymol 
nano polymer (30,60 and 90 mg/kg, respectively), as with the 
diabetic group treated with glibenclamide 2.5 mg/kg, serum insulin 
levels significantly increased compared to diabetic group. In this 
study, the highest insulin secretion into serum was observed in the 
diabetic group treated with thymol nano polymer 90 mg/kg (group 
10). However, this effect did not have a significant difference with 
the group treated with glibenclamide 2.5 mg/kg (table 3, P<0.05). 
 
Table 1: Effects of thymol and thymol nano polymer on body weight (g) in STZ-induced diabetic rats and normal rat 
Number Treatment groups Initial body weight (g) Secondary body weight (g) 
1 Diabetic rat+normal Saline 240.5±1.5 205.2±1.3* 
2 Non Diabetic rat+normal Saline 245.2±1.6 293.3±1.9# 
3 Non Diabetic rat+thymol 60 mg/kg 247.6±2.1 281.8±2.6*# 
4 Non Diabetic rat+thymol nano polymer 60 mg/kg 251.3±0.8 287.6±1.4* 
5 Diabetic rat+thymol 30 mg/kg 248.4±1.2 231.1±0.9 
6 Diabetic rat+thymol 60 mg/kg 250.8±1.7 210.2±1.1* 
7 Diabetic rat+thymol 90 mg/kg 252.1±2.1 201.4±2.7* 
8 Diabetic rat+thymol nano polymer 30 mg/kg 249.5±1.7 218.9±2.3* 
9 Diabetic rat+thymol nano polymer 60 mg/kg 247.7±1.5 205.5±0.7* 
10 Diabetic rat+thymol nano polymer 90 mg/kg 251.6±2.2 199.4±1.3* 
11 Diabetic rat+glibenclamide 2.5 mg/kg 245.9±1.8 203.7±1.6* 
Notes,±: Standard Error of the Mean; Significant differences each group versus diabetic rats are indicated: *p<0:05; Significant differences each 
group versus non diabetic rats are indicated: #p<0:05. 
 
Table 2: Effect of thymol and thymol nano polymer on blood glucose in STZ-induced diabetic rats and normal rats 
Number of groups Treatment groups BG mg/dl 
1 Diabetic rat+normal saline 510.11±5.21* 
2 Non Diabetic rat+normal saline 91.31±3.24 
3 Non Diabetic rat+thymol 60 mg/kg 82.44±2.9 
4 Non Diabetic rat+thymol nano polymer 60 mg/kg 87.35±2.3 
5 Diabetic rat+thymol 30 mg/kg 410.71±4.43* 
6 Diabetic rat+thymol 60 mg/kg 380.63±4.9* 
7 Diabetic rat+thymol 90 mg/kg 320.12±4.1* 
8 Diabetic rat+thymol nano polymer30 mg/kg 303.67±2.9* 
9 Diabetic rat+thymol nano polymer60 mg/kg 300.45±3.38* 
10 Diabetic rat+thymol nano polymer90 mg/kg 180.40±2.91 
11 Diabetic rat+glibenclamide 2.5 mg/kg 160.35±2.31 
Notes,±: Standard Error of the Mean; Significant differences each group versus diabetic rats are indicated: *p<0:05; Significant differences each 
group versus non-diabetic rats are indicated: #p<0:05. 
 
Table 3: Effect of thymol and thymol nano polymer on serum insulin in STZ-induced diabetic rats and normal rats 
Number Treatment groups INSULIN mIU/ml 
1 Diabetic rat+normal saline 6.21±0.5* 
2 Non Diabetic rat+normal saline 15.12±1.6# 
3 Non Diabetic rat+thymol 60 mg/kg 14.39±2.2 
4 Non Diabetic rat+thymol nano polymer 60 mg/kg 14.81±0.9 
5 Diabetic rat+thymol 30 mg/kg 8.37±0.8* 
6 Diabetic rat+thymol 60 mg/kg 10.61±1.3 
7 Diabetic rat+thymol 90 mg/kg 11.54±1.2 
8 Diabetic rat+thymol nano polymer 30 mg/kg 16.19±0.71 
9 Diabetic rat+thymol nano polymer 60 mg/kg 17.32±0.8 
10 Diabetic rat+thymol nano polymer 90 mg/kg 18.71±1.0 
11 Diabetic rat+glibenclamide 2.5 mg/kg 16.32±1.2 
Notes,±: Standard Error of the Mean; Significant differences each group versus diabetic rats are indicated: *p<0:05; Significant differences each 
group versus non-diabetic rats are indicated: #p<0:05. 
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Evaluation of the effect of thymol and thymol nano polymer on 
hepatic markers 
Our results ascertained the liver function by evaluating the major 
biochemical indicators of liver functions, including ALT, AST, ALP 
and bilirubin. As expected, the inductions of diabetes by STZ lead to 
a significant elevation of the indicators when compared to the 
control animals (fig. 5-fig. 8). Thymol and thymol nano polymer 
could significantly lower the levels of the elevated liver parameters. 
 
 
Fig. 5: Effect of thymol and thymol nano polymer on the liver marker enzyme alanine amino transferase (ALT) in STZ-induced diabetic 
rats and normal rat. Normal: non diabetic rat+normal saline, D: Diabetic rat+normal saline, D+TY 30: Diabetic rat+thymol 30 mg/kg, 
D+TY 60: Diabetic rat+thymol 60 mg/kg, D+TY 90: Diabetic rat+thymol 90 mg/kg, D+NTY 30: Diabetic rat+thymol nano polymer 30 
mg/kg, D+NTY 60: Diabetic rat+thymol nano polymer 60 mg/kg, D+NTY 90: Diabetic rat+thymol nano polymer 90 mg/kg. Significant 
differences each group versus diabetic rats are indicated; *p<0:05 
 
 
Fig. 6: Effect of thymol and thymol nano polymer on the liver marker enzyme aspartate aminotransferase (AST) in STZ-induced diabetic 
rats and normal rat. Normal: non diabetic rat+normal saline, D: Diabetic rat+normal Saline, D+TY 30: Diabetic rat+thymol 30 mg/kg, 
D+TY 60: Diabetic rat+thymol 60 mg/kg, D+TY 90: Diabetic rat+thymol 90 mg/kg, D+NTY 30: Diabetic rat+thymol Nano polymer 30 
mg/kg, D+NTY 60: Diabetic rat+thymol nano polymer 60 mg/kg, D+NTY 90: Diabetic rat+thymol nano polymer 90 mg/kg. Significant 
differences each group versus diabetic rats are indicated; *p<0:05 
 
 
Fig. 7: Effect of thymol and thymol nano polymer on the liver marker enzyme alkaline phosphatase (ALP) in STZ-induced diabetic rats and 
normal rat. Normal: non diabetic rat+normal saline, D: Diabetic rat+normal saline, D+TY 30: Diabetic rat+thymol 30 mg/kg, D+TY 60: 
Diabetic rat+thymol 60 mg/kg, D+TY 90: Diabetic rat+thymol 90 mg/kg, D+NTY 30: Diabetic rat+thymol nano polymer30 mg/kg, D+NTY 
60: Diabetic rat+thymol nano polymer 60 mg/kg, D+NTY 90: Diabetic rat+thymol nano polymer 90 mg/kg. Significant differences each 
group versus diabetic rats are indicated; *p<0:05 
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Fig. 8: Effect of thymol and thymol nano polymer on the liver marker enzyme total bilirubin in STZ-induced diabetic rats and normal rat. 
Normal: non diabetic rat+normal saline, D: Diabetic rat+normal saline, D+TY 30: Diabetic rat+thymol 30 mg/kg, D+TY 60: Diabetic 
rat+thymol 60 mg/kg, D+TY 90: Diabetic rat+thymol 90 mg/kg, D+NTY 30: Diabetic rat+thymol nano polymer 30 mg/kg, D+NTY 60: 
Diabetic rat+thymol nano polymer 60 mg/kg, D+NTY 90: Diabetic rat+thymol nano polymer 90 mg/kg. Significant differences each group 
versus diabetic rats is indicated; *p<0:05 
 
DISCUSSION 
To reduce the side-effects and dosing intervals, researchers are now 
focusing on drug delivery systems. In this regard, some components 
of medicinal plants such as thymol, with a terpenoids structure, are 
used for a variety of disorders and diseases [29]. Thus, this is the 
first study that was initiated with the aim of evaluating the effect of 
thymol and thymol nano polymer on the blood biochemical 
parameters and anti-diabetic activity in Streptozotocin-induced 
diabetic rats. The efficacy was compared with glibenclamide, a 
standard hypoglycemic drug. Recent research has focused on the 
possibility using hyperbranched and functionalized polymers to 
enhance the efficiency of drug delivery systems due to their specific 
characteristics such as low viscosity, high solubility, plenty of 
terminal groups and lack of chain entanglements [30, 31]. Due to 
factors such as small size and excellent biocompatibility, nano 
polymers modified by oleic acid(NP) are easily fluid in the 
bloodstream and will reach target tissues as well as increase binding 
to cell receptors [32]. This polymer has some cavities for loading 
drugs and used for loading thymol as a diabetes drug release system. 
It seems that all interactions between thymol and NP were non-
covalent [33, 34]. In an investigation of nanoparticles, citric glycerol 
hyperbranched polyester was synthesized in different 
concentrations that were monitored cisplatin as an anticancer drug 
for loading in polyester [20].  
In this study, different analytical techniques have been used to get 
NP structure, including Fourier transforms infrared (FTIR), 1H and 
13C nuclear magnetic resonance (NMR). The FTIR spectrum 
demonstrated in nano polymer (NP) carbon derived from the 
carbonyl group at 1738 cm-1 and the hydroxyl group at 3485 cm-1. 
The 1HNMRspectrum showed that there are 7 types of hydrogens. 
Hydrogen A is at 4.37 ppm. Hydrogen B is at 3.87 ppm. Hydrogen C 
is methylated glycerol, which has two separate couriers due to the 
presence of neighbor hydrogen. Hydrogen D is at 2.45 ppm due to 
the presence of two hydrogen neighbors. Hydrogen E is a methyl 
group adjacent to hydrogen D. Hydrogen F appears in a single-pixel 
at 2 ppm because of the same space-spatial position. Hydrogen I has 
a peak in the range of 2.2 to 2.3 ppm. The G-hydrides appear to be in 
the form of a double peak at 5.26 ppm. Hydrogen J is a multiplicative 
peak at 1.15 ppm appear. 
The 13CNMR spectrum of the NPMO compound displays 12 types of 
carbon in the synthetic composition. Carbon A is displacement of 
177 ppm and carbon B is at 42 ppm. Methionine citric acid 
carbonated with the letter C appears at 28 ppm and carbon D 
appears at 172 ppm. Carbon E is given at 73 ppm and F, which 
appear as a peak at the highest intensity of 68 ppm. Carbon G, has 
the largest displacement and peak at 183 ppm. Carbon H marked 
with a peak of 38 ppm and "I" has a roughly identical position at 26 
ppm. The adjacent dual-carbon carbons J have a peak at 21 ppm and 
K appears as a peak at 130 ppm. At the end of the carbon, the methyl 
group has appeared with a minimum displacement of 9 ppm. 
By HPLC method, it is possible to evaluate the amount of NP loading 
capacity.
35
 In this analysis, subsequent to drawing standard curve 
amount of the loading rate of thymol was estimated at 43±2.5%. In 
one study, chitosan nanoparticle of thymol with anti-bacterial effects 
had a loading capacity of about 2.5% [ ]. However, in another 
study, thymol nanospheres as an effective anti-bacterial agent, 
similar to that of our study, was reported to be about 43 % [36]. 
In our study, approximately 65% of thymol from the NP in the first 
12 h (fast phase) and the remaining 80-85% in the next 48 h was 
released with slower kinetics and less slope, which indicated two 
phases the release of thymol from NP. The initial and rapid release of 
the drug from the polymer is more closely related to the particles of 
the drug that are surface-coated with nano polymers, and thus the 
release of the drug increases [37]. In a study, it has been shown that 
thymol has released about 60% of nanoparticles from natural lipids 
for up to 18 h [38]. In another study, it has been shown that thymol 
loaded with hierarchically-structured biogenic silica in the first 48 h 
has been released about 50% of thymol [39].  
Our result of the acute toxicity test showed that the LD50 for thymol 
and thymol nano polymer was 435 and 583 mg/kg, respectively. In 
one study, Tephrosia calophylla extract has improved the symptoms 
of diabetics caused by alloxan-induced with a significantly IC50value 
400 mg/kg [40]. 
Previous investigations showed that thymol has various anti-
diabetic effects, especially type II diabetes [41, 42]. Decreased body 
weight in STZ diabetic animals is associated with increased blood 
glucose, inhibition of insulin level, and enhancement of muscle 
wasting [43, 44]. 
Our results indicated that there was no significant difference in body 
weight between groups before induction of diabetes. Diabetes 
symptoms appeared such as weight loss when compared with the 
untreated diabetic rats. Weight loss, in the group treated with 
thymol nano-polymer 90 mg/kg, similar to diabetic group. In a study 
similar to this study, it has been shown that the weight of diabetic 
rats has significantly decreased. However, the use of different 
concentrations of Zataria multiflora extract, which contains thymol 
and carvacrol [45], has not been able to reduce the weight of the 
diabetic control group in diabetic rats [46]. Also, according to the 
previous study, Thymus praecox subsp. skorpilii,which contains 
thymol, significantly decreased enhanced oral glucose tolerance, 
insulin tolerance and weight loss [47]. 
Our results showed that after induction diabetes, in untreated 
diabetic rats, serum glucose levels increased compared to non-
diabetic rats. Treatment with thymol and thymol nano polymer 
reduced the glucose concentration in diabetic rats by dose-
dependent manner. Also, the results from this study showed that in 
the groups treated with thymol and thymol nano polymer, as with 
the diabetic group treated with glibenclamide, serum insulin levels 
significantly increased compared to the diabetic group. Previous 
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studies, in confirmation of our study, have shown that increase 
blood glucose levels and decrease insulin levels in STZ diabetic rats, 
confirmed that hyperglycemia is a main cause for disruption of 
insulin in the optimal rate [16, 41, 42] Moreover, in one research 
treatment by thymol led to a significant reduces in the blood glucose 
level and increase in serum insulin level after 28 d in the STZ-
induced diabetic rats [48]. However, the anti-diabetic mechanism of 
thymol, which is responsible for increasing the rate of serum insulin 
secretion and decreasing of blood glucose, is still unclear [42]. 
Our results demonstrated the liver function by evaluating the major 
biochemical indicators of liver functions, such as ALT, AST, ALP and 
bilirubin. As expected, the inductions of diabetes by STZ lead to a 
significant elevation of the indicators when compared to the non-
diabetic animals. In all the tested parameters, the liver functions of 
the diabetes-induced rats could be significantly improved by thymol 
and thymol nano polymer. ALT and AST are the important hepatic 
enzymes due to their levels in serum as the specific and reliable 
biomarker for liver damages [42, 49, 50]. In confirmation of our 
results, it was shown in a paper that thymol 40 mg/kg has been able 
to significantly reduce ALT and AST in diabetic rats by STZ and help 
animal health [48]. It has been documented that the Zataria 
multiflora essential oil has been able to protect the increase of ALP 
produced by STZ in diabetic rats [51]. It has already been 
documented that the ethanolic extract of the Artocarpus 
heterophyllus, which contains terpenoids, reduces the amount of 
bilirubin in diabetic rats in a dose-dependent manner [52]. Also, the 
aqueous extract of the Canarium odontophyllum, containing 
terpenoid and flavonoid, reduced the amount of total bilirubin in 
streptozotocin-induced diabetic rats [53]. 
CONCLUSION 
Thymol and thymol nano polymer affected by increasing insulin 
secretion, lowering blood glucose, and improving the function of 
liver enzymes in STZ-diabetic rats. The effects of thymol nano 
polymer on improving the above mentioned were greater than 
thymol. The use of thymol nano polymer seems to be of interest to 
diabetics as alternative medicine. 
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